Combined hepatocellular carcinoma and cholangiocarcinoma Advocacy Hub | UniteRare

At a Glance

Live from database

💊

Regulatory Watchboard

10 events

Jan 2026Biannual Screening for HCC Offered to Patients With Cirrhosis. Introducing Surveillance for Hepatocellular Carcinoma (HCC) in the Central Denmark Region Using Ultrasound and Alpha-Fetoprotein to Reduce HCC-Related Mortality in Patients With Compensated Non-Viral Cirrhosis

University of Aarhus — NA

TrialRECRUITING

Dec 2025DEB-TACE vs cTACE in HCC After TIPS

First Affiliated Hospital, Sun Yat-Sen University — PHASE3

TrialRECRUITING

Sep 2025Role of Long Noncoding RNA LINC01134 in Metastasis of Hepatitis C Virus-related Hepatocellular Carcinoma

Sohag University

TrialNOT YET RECRUITING

Jul 2025Continuation of First-line Therapy With Radiotherapy Versus Early Switch to Second-line Therapy in Oligoprogressive HCC

Shandong Cancer Hospital and Institute — PHASE3

TrialRECRUITING

Mar 2025A Phase II Single-Arm Clinical Study to Evaluate the Efficacy and Safety of Carbon Ion Radiotherapy With Atezolizumab and Bevacizumab Combination Therapy in Patients With Advanced Hepatocellular Carcinoma

Yonsei University — PHASE2

TrialRECRUITING

Mar 2025A Prospective, Multicenter, Phase II Clinical Study on the Treatment of Unresectable Advanced HCC with DEB-TACE Combined with SALOX-HAIC

Xuhua Duan

TrialNOT YET RECRUITING

Feb 2025naVIGation Invitations Liver surveillANce upTake

Imperial College London

TrialACTIVE NOT RECRUITING

Feb 2025Comparative Study of Carvedilol Monotherapy Versus Combination Therapy With Endoscopic Variceal Ligation (EVL) for Primary Prophylaxis of Variceal Bleeding in Patients With Hepatocellular Carcinoma With High-Risk Esophageal Varices

Institute of Liver and Biliary Sciences, India — NA

TrialNOT YET RECRUITING

Jan 2025Fusing Ultrasound and Magnetic Resonance Imaging to Intelligently Plan Highly Conformal Ablation Thermal Field for Hepatocellular Carcinoma

Chinese PLA General Hospital

TrialNOT YET RECRUITING

Nov 2024Active Choice Clinical Decision Support (CDS): Hepatocellular Carcinoma (HCC) Screening in Patients With Cirrhosis

NYU Langone Health

TrialENROLLING BY INVITATION

Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Financial Assistance

3 programs

FINANCIAL LANDSCAPE SUMMARY

Total programs

Open now

Copay cards

Copay Assistance2

Truseltiq

QED Therapeutics, Inc.

OpenContact for details

Lytgobi

Taiho Oncology, Inc.

OpenContact for details

Patient Assistance Programs1

Yervoy

Bristol-Myers Squibb Company

OpenContact for detailsApply ↗

View all support programs on disease page →

Approved Treatments

3 FDA-approved

Lytgobi

(futibatinib)Orphan drug

Taiho Oncology, Inc.

Approved Sep 2022

Truseltiq

(infigratinib)Orphan drug

QED Therapeutics, Inc.

Approved May 2021

Tibsovo

(IVOSIDENIB)Orphan drugstandard

Servier Pharmaceutical LLC

Isocitrate Dehydrogenase 1 Inhibitor [EPC]

12.1 Mechanism of Action Ivosidenib is a small molecule inhibitor that targets the mutant isocitrate dehydrogenase 1 (IDH1) enzyme. In patients with A...

FDA label ↗

View full treatment details on disease page →

Clinical Trial Landscape

22 active trials

4Phase 3

1Phase 4

3Phase 2

1Phase 1

6N/A

5Unknown

1PHASE1, PHASE2

1EARLY_PHASE1

22Total recruiting

Search clinical trials for Combined hepatocellular carcinoma and cholangiocarcinoma →

Recent News & Research

No recent news articles indexed yet for Combined hepatocellular carcinoma and cholangiocarcinoma.
Search PubMed for Combined hepatocellular carcinoma and cholangiocarcinoma →

Browse all Combined hepatocellular carcinoma and cholangiocarcinoma news →

Specialist Network

Top 6 by expertise

Manuel Häckl, MD

Basilea Pharmaceutica International Ltd, Allschwil

Score 185 trials

Nilofer S Azad, MD

JHU Sidney Kimmel Comprehensive Cancer Center LAO

📍 BALTIMORE, MD

Score 163 trials1 pub

Richard Kim

SWOG Cancer Research Network

Score 91 trial

David Hsieh

ECOG-ACRIN Cancer Research Group

Score 81 trial4 pubs

Dustin A Deming, M.D

ECOG-ACRIN Cancer Research Group

📍 MADISON, WI

Score 81 trial

Tim F Greten, M.D., M.D

National Cancer Institute (NCI)

📍 BETHESDA, MD

Score 78 trials

View all Combined hepatocellular carcinoma and cholangiocarcinoma specialists →

Quick Actions

📄

View Disease Page

Full profile, treatments, community

🔬

Search Clinical Trials

Find recruiting studies now

🩺

Find Specialists

Ranked by expertise & trials

💰

Financial Assistance

Copay cards, PAPs, grants

📰